Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fam-Trastuzumab Deruxtecan-Nxki
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
C
(37)
Tucatinib
Solid Tumor, Adult
QuantumLeap Healthcare Collaborative
P1
C
(37)
Zanidatamab
Solid Tumor, Adult
QuantumLeap Healthcare Collaborative
P1
C
(37)
Showing 276 to 278 of 278 assets
Previous
Page 12 of 12
Next
